sign in sign up
<<
Home , Dimethoxyamphetamine

Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices 73629

of the listed controlled substances in granted registration as a bulk Dated: November 25, 2014. bulk and to conduct analytical testing in manufacturer of the basic classes of Joseph T. Rannazzisi, support of the company’s primary controlled substances listed: Deputy Assistant Administrator. manufacturing facility in West Deptford, [FR Doc. 2014–29119 Filed 12–10–14; 8:45 am] New Jersey. The controlled substances Controlled substance Schedule BILLING CODE 4410–09–P manufactured in bulk at this facility will be distributed to the company’s (1235) ...... I (1237) ...... I customers. DEPARTMENT OF LABOR (4-Methyl-N- I Dated: November 25, 2014. methylcathinone) (1248). Joseph T. Rannazzisi, Employee Benefits Security (1585) ...... I Administration Deputy Assistant Administrator. Alpha-ethyltryptamine (7249) ...... I [FR Doc. 2014–29117 Filed 12–10–14; 8:45 am] Lysergic acid diethylamide (7315) I Proposed Extension of Information BILLING CODE 4410–09–P Tetrahydrocannabinols (7370) ..... I Collection Request Submitted for 4-Bromo-2,5- I Public Comment; Revisions to dimethoxyamphetamine (7391). Coverage of Certain Preventive DEPARTMENT OF JUSTICE 4-Bromo-2,5- I Services Under the Affordable Care dimethoxyphenethylamine Act Enforcement Administration (7392). 4-Methyl-2,5- I AGENCY: [Docket No. DEA–392] Employee Benefits Security dimethoxyamphetamine (7395). Administration, Department of Labor. 2,5-Dimethoxyamphetamine I ACTION: Notice. Manufacturer of Controlled (7396). Substances Registration: Sigma 3,4-Methylenedioxyamphetamine I SUMMARY: The Department of Labor (the Aldrich Research Biochemicals, Inc. (7400). Department), in accordance with the AGENCY: Drug Enforcement N-Hydroxy-3,4- I Paperwork Reduction Act of 1995 (PRA Administration, Department of Justice. methylenedioxyamphetamine 95) (44 U.S.C. 3506(c)(2)(A)), provides (7402). ACTION: Notice of registration. the general public and Federal agencies 3,4-Methylenedioxy-N- I with an opportunity to comment on ethylamphetamine (7404). SUMMARY: Sigma Aldrich Research proposed and continuing collections of 3,4- I Biochemicals, Inc., applied to be Methylenedioxymethamphetam- information. This helps the Department registered as a manufacturer of certain ine (MDMA) (7405). assess the impact of its information basic classes of controlled substances. Dimethyltryptamine (7435) ...... I collection requirements and minimize The DEA grants Sigma Aldrich Research Psilocybin (7437) ...... I the reporting burden on the public and Biochemicals, Inc. registration as a 5-Methoxy-N, N- I helps the public understand the manufacturer of those controlled diisopropyltryptamine (7439). Department’s information collection substances. 1-[1-(2- I requirements and provide the requested SUPPLEMENTARY INFORMATION: By notice Thienyl)cyclohexyl]piperidine data in the desired format. Currently, dated January 15, 2014, and published (TCP) (7470). the Employee Benefits Security in the Federal Register on February 4, N- (BZP) (7493) I Administration is soliciting comments 2014, 79 FR 6633, Sigma Aldrich MDPV (3,4- I on the revision of the Coverage of Methylenedioxypyrovalerone) Research Biochemicals, Inc. 1–3 Certain Preventive Services Under the (7535). Affordable Care Act information Strathmore Road, Natick, Massachusetts (3,4-Methylenedioxy-N- I 01760–2447, applied to be registered as collection to reflect the new option of methylcathinone) (7540). notifying the Department of Health and a manufacturer of certain basic classes Heroin (9200) ...... I Human Services of the respondents’ of controlled substances. No comments Normorphine (9313) ...... I objections to providing coverage in or objections were submitted to this (1100) ...... II response to the Supreme Court of the notice. (1105) ...... II The Drug Enforcement Nabilone (7379) ...... II United States’ interim order in Administration (DEA) has considered 1-Phenylcyclohexylamine (7460) II connection with an application for an the factors in 21 U.S.C. 823(a) and (7471) ...... II injunction in the pending case of determined that the registration of (9041) ...... II Wheaton College v. Burwell. A copy of Sigma Aldrich Research Biochemicals, Codeine (9050) ...... II the information collection request (ICR) Inc. to manufacture the basic classes of Ecgonine (9180) ...... II may be obtained by contacting the office controlled substances is consistent with Levomethorphan (9210) ...... II listed in the ADDRESSES section of this the public interest and with United Levorphanol (9220) ...... II notice. States obligations under international Meperidine (9230) ...... II DATES: Written comments must be treaties, conventions, or protocols in Metazocine (9240) ...... II submitted to the office shown in the effect on May 1, 1971. The DEA Methadone (9250) ...... II Addresses section on or before February investigated the company’s maintenance Morphine (9300) ...... II 9, 2015. of effective controls against diversion by Thebaine (9333) ...... II ADDRESSES: Direct all written comments inspecting and testing the company’s Levo-alphacetylmethadol (9648) .. II regarding the information collection physical security systems, verifying the Remifentanil (9739) ...... II request and burden estimates to G. company’s compliance with state and Sufentanil (9740) ...... II Christopher Cosby, Office of Policy and local laws, and reviewing the company’s Carfentanil (9743) ...... II Research, Employee Benefits Security background and history. Fentanyl (9801) ...... II Administration, U.S. Department of Therefore, pursuant to 21 U.S.C. Labor, 200 Constitution Avenue NW., 823(a), and in accordance with 21 CFR The company plans to manufacture Room N–5718, Washington, DC 20210. 1301.33, the above named company is reference standards. Telephone: (202) 693–8410; Fax: (202)

VerDate Sep<11>2014 19:07 Dec 10, 2014 Jkt 235001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\11DEN1.SGM 11DEN1 mstockstill on DSK4VPTVN1PROD with NOTICES